S 293
105th Congress
Senate
Taxation
Business income tax
Clinical trials
Commerce
Diseases
Drug industry
Health
Income tax
Orphan drugs
Pharmaceutical research
Science, Technology, Communications
Tax credits
A bill to amend the Internal Revenue Code of 1986 to make permanent the credit for clinical testing expenses for certain drugs for rare diseases or conditions.
Introduced: February 10, 1997
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 10, 1997
Read twice and referred to the Committee on Finance.
Feb 10, 1997
Sponsor introductory remarks on measure. (CR S1191-1192)
Feb 10, 1997
Introduced in Senate
Plain-English summary
Amends the Internal Revenue Code to extend permanently the tax credit for expenses of clinical testing of certain drugs for rare diseases or conditions.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1